Skip to content

Post-market Evaluation of OdySight App to Monitor Near Visual Acuity at Home (TIL002)

Post-market Study for At-home Evaluation of Near Visual Acuity With OdySight, a Smartphone Based Medical Application in Comparison to a Standardized Method (TIL002)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05510479
Acronym
TIL002
Enrollment
58
Registered
2022-08-22
Start date
2021-05-05
Completion date
2022-05-11
Last updated
2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Impairment

Keywords

Visual acuity, Digital therapeutics, Medical software, ETDRS, Macular Edema, Age-related Macular Degeneration

Brief summary

OdySight is a mobile application allowing self-testing of visual parameters including near visual acuity and communication of the data to an online dashboard to patient's doctors. TIL-002 post-market clinical trial objective is to evaluate the near visual acuity at home, measured with OdySight application in comparison to the standardized methods. The clinical trial is intended to prove that OdySight can provide relevant data and participate in the remote monitoring of subject vision.

Interventions

OTHERSoftware as medical device

At home measurements of visual acuity through a mobile app

Sponsors

Tilak Healthcare
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

General inclusion criteria: 1. Age ≥ 18 years, all genders 2. Affiliated to or beneficiary of the French health care system 3. Signed/written informed consent 4. Already user of Odysight on a compatible smartphone/tablet 5. Patients willing and able to comply with all study and follow-up procedure Ophthalmic inclusion criterion: 6. Baseline binocular visual acuity with habitual correction ≥ 20/63 (3/10) AND with at least an eye ≥ 20/200 (1/10).

Exclusion criteria

General

Design outcomes

Primary

MeasureTime frameDescription
Equivalence between OdySight and standardized methods - Near Visual Acuity2 monthsTo assess the equivalence between a smartphone based evaluation of near visual acuity with ODYSIGHT at home and standardized methods (Sloan ETDRS near vision letter chart and Landolt C near vision chart) performed in clinic.

Secondary

MeasureTime frameDescription
Equivalence between OdySight and standardized methods - 4-meter distance Visual Acuity2 monthsETDRS visual acuity at a 4-meter distance at clinic and near visual acuity evaluated with ODYSIGHT at home.

Other

MeasureTime frameDescription
Near Visual Acuity - Subgroups analysis2 monthsTo assess the equivalence between a smartphone based evaluation of near visual acuity with ODYSIGHT at home and with standardized methods in specific subgroups defined by visual acuity and by pathology
Near Visual Acuity variability2 monthsTo assess variability of measurements with a smartphone-based evaluation of NVA with Odysight at home vs at clinic
Vision changes tracking2 monthsTo evaluate ability of the VA application module to track vision change over time as compared to standardized methods.
Compliance to OdySight2 monthsTo evaluate compliance of daily use among time.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026